Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J. bras. nefrol ; 42(2,supl.1): 49-50, 2020.
Article in English | LILACS | ID: biblio-1134830

ABSTRACT

ABSTRACT Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment.


RESUMO Em razão de resultados preliminares promissores, a hidroxicloroquina e a cloroquina têm sido discutidas como opção terapêutica para pacientes com Covid-19. Apesar da ausência de estudos robustos que evidenciem o benefício e justifiquem o uso de uma dessas drogas, a decisão final compete ao médico assistente, devendo ser individualizada e, sempre que possível, compartilhada. A presente nota pretende orientar o ajuste posológico dessas drogas no contexto da disfunção renal.


Subject(s)
Humans , Pneumonia, Viral/drug therapy , Chloroquine/administration & dosage , Coronavirus Infections/drug therapy , Renal Insufficiency , Hydroxychloroquine/administration & dosage , Antimalarials/administration & dosage , Societies, Medical , Brazil , Pandemics , COVID-19 , Nephrology
2.
J. bras. nefrol ; 42(2,supl.1): 4-8, 2020. graf
Article in English | LILACS | ID: biblio-1134833

ABSTRACT

ABSTRACT The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19.


RESUMO A pandemia da Covid-19 trouxe desafios ao sistema de saúde em diversas esferas: diagnóstico, tratamento e medidas para evitar a disseminação da doença. Com a maior disponibilização e variedades de testes diagnósticos, torna-se fundamental sua adequada interpretação. Este posicionamento pretende orientar unidades de diálise em relação ao uso de critérios clínicos e testes diagnósticos para a tomada de decisão referente à descontinuação do isolamento de pacientes com suspeita ou confirmação de Covid-19, assim como para o retorno às atividades laborais de colaboradores com suspeita ou confirmação de Covid-19.


Subject(s)
Humans , Pneumonia, Viral/diagnosis , Renal Dialysis , Coronavirus Infections/diagnosis , Clinical Laboratory Techniques/standards , Return to Work , Betacoronavirus , Nephrology/standards , Patient Isolation , Pneumonia, Viral/epidemiology , Societies, Medical/standards , Algorithms , Brazil , Urology Department, Hospital/standards , Clinical Laboratory Techniques/methods , Checklist , Pandemics , Real-Time Polymerase Chain Reaction/methods , Clinical Decision-Making , COVID-19 Testing , SARS-CoV-2 , COVID-19
SELECTION OF CITATIONS
SEARCH DETAIL